EC Healthcare provided sales guidance for the second half and full year ended 31 March 2023. For the second half, the group expected overall sales volume increased by 27% based on year on year growth.

For the year, the group expected overall sales volume of no less than HKD 3,800 million, representing an increase of no less than 24% as compared with the same period last year.